bile duct cancer
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2022/03/eyeem-100007350-89430829.jpg)
Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2022/02/GettyImages-1284268018.jpg)
Chemoradiation followed by liver transplant is being used more widely to treat perihilar cholangiocarcinoma, the most common form of bile duct cancer.
![](https://cdn.prod-carehubs.net/n1/64bf9b8fff067424/uploads/2020/12/ff-vol8iss1-tile-liver.png)
A team of researchers from the Mayo Clinic Cancer Center has been awarded a five-year, $11.5-million Specialized Program of Research Excellence (SPORE) grant in hepatobiliary[...]